H Raza Ali
H Raza Ali
Group Leader, CRUK Cambridge Institute, University of Cambridge
Adresse e-mail validée de cruk.cam.ac.uk - Page d'accueil
Titre
Citée par
Citée par
Année
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
13002012
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...
Annals of oncology 25 (8), 1536-1543, 2014
5352014
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 1-6, 2015
3782015
Prognostic and predictive value of PDL1 expression in breast cancer
R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ...
Oncotarget 6 (7), 5449, 2015
3772015
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
3582012
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
2982013
Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study
HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas
PLoS medicine 13 (12), e1002194, 2016
2862016
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes
HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ...
Annals of Oncology 26 (7), 1488-1493, 2015
2202015
The single-cell pathology landscape of breast cancer
HW Jackson, JR Fischer, VRT Zanotelli, HR Ali, R Mechera, SD Soysal, ...
Nature 578 (7796), 615-620, 2020
2042020
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ...
Genome biology 15 (8), 1-14, 2014
1782014
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
1412016
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
WT Khaled, SC Lee, J Stingl, X Chen, HR Ali, OM Rueda, F Hadi, J Wang, ...
Nature communications 6 (1), 1-10, 2015
1162015
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ...
Nature 567 (7748), 399-404, 2019
1142019
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ...
EMBO molecular medicine 3 (3), 167-180, 2011
1132011
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas
Breast Cancer Research 13 (6), 1-15, 2011
1112011
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer
HR Ali, SJ Dawson, FM Blows, E Provenzano, S Leung, T Nielsen, ...
The Journal of pathology 226 (1), 97-107, 2012
832012
Biological and prognostic associations of miR‐205 and let‐7b in breast cancer revealed by in situ hybridization analysis of micro‐RNA expression in arrays of …
JL Quesne, J Jones, J Warren, SJ Dawson, HR Ali, H Bardwell, F Blows, ...
The Journal of pathology 227 (3), 306-314, 2012
792012
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas
British journal of cancer 106 (11), 1798-1806, 2012
792012
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
HR Ali, HW Jackson, VRT Zanotelli, E Danenberg, JR Fischer, H Bardwell, ...
Nature Cancer 1 (2), 163-175, 2020
652020
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
M Álvarez-Fernández, M Sanz-Flores, B Sanz-Castillo, M Salazar-Roa, ...
Cell Death & Differentiation, 1-13, 2017
612017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20